https://médecine.top/index.php?action=history&feed=atom&title=Fonction_parathyro%C3%AFdienne 2026-09-02T05:43:53Z Historique des révisions pour cette page sur le wiki MediaWiki 1.35.2 https://médecine.top/index.php?title=Fonction_parathyro%C3%AFdienne&diff=4940&oldid=prev 2024-01-30T07:46:43Z

<p><span dir="auto"><span class="autocomment">Hyperparathyroïdie secondaire</span></span></p> <table class="diff diff-contentalign-left diff-editfont-monospace" data-mw="interface"> <col class="diff-marker" /> <col class="diff-content" /> <col class="diff-marker" /> <col class="diff-content" /> <tr class="diff-title" lang="fr"> <td colspan="2" style="background-color: #fff; color: #202122; text-align: center;">← Version précédente</td> <td colspan="2" style="background-color: #fff; color: #202122; text-align: center;">Version du 30 janvier 2024 à 07:46</td> </tr><tr><td colspan="2" class="diff-lineno" id="mw-diff-left-l17" >Ligne 17 :</td> <td colspan="2" class="diff-lineno">Ligne 17 :</td></tr> <tr><td class='diff-marker'> </td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>=== Hyperparathyroïdie secondaire ===</div></td><td class='diff-marker'> </td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>=== Hyperparathyroïdie secondaire ===</div></td></tr> <tr><td class='diff-marker'> </td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>* &lt;u&gt;Etiologie:&lt;/u&gt;&lt;ref&gt;https://www.revmed.ch/revue-medicale-suisse/2015/revue-medicale-suisse-456-57/endocrinologie-l-hyperparathyroidie-primaire-asymptomatique-en-2014&lt;/ref&gt;</div></td><td class='diff-marker'> </td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>* &lt;u&gt;Etiologie:&lt;/u&gt;&lt;ref&gt;https://www.revmed.ch/revue-medicale-suisse/2015/revue-medicale-suisse-456-57/endocrinologie-l-hyperparathyroidie-primaire-asymptomatique-en-2014&lt;/ref&gt;</div></td></tr> <tr><td class='diff-marker'>−</td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;"><div>** [[<del class="diffchange diffchange-inline">insuffisance </del>rénale chronique]] (eGFR &lt;60-30 ml/min)</div></td><td class='diff-marker'>+</td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div>** [[<ins class="diffchange diffchange-inline">Insuffisance </ins>rénale chronique]] (eGFR &lt;60-30 ml/min)</div></td></tr> <tr><td class='diff-marker'>−</td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;"><div>** Médicaments: biphosphonates, anti-épileptiques, furosémide, phosphore</div></td><td class='diff-marker'>+</td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div>** <ins class="diffchange diffchange-inline">&#039;&#039;&#039;</ins>Médicaments:<ins class="diffchange diffchange-inline">&#039;&#039;&#039; </ins>biphosphonates, anti-épileptiques, furosémide, phosphore</div></td></tr> <tr><td class='diff-marker'>−</td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;"><div>** Malabsorption ou apports calciques diminués: maladie coeliaque, mucoviscidose, maladie de Crohn, status après [[bypass gastrique]]</div></td><td class='diff-marker'>+</td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div>** <ins class="diffchange diffchange-inline">&#039;&#039;&#039;</ins>Malabsorption ou apports calciques diminués:<ins class="diffchange diffchange-inline">&#039;&#039;&#039; </ins>maladie coeliaque, mucoviscidose, maladie de Crohn, status après [[bypass gastrique]]</div></td></tr> <tr><td class='diff-marker'>−</td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;"><div>** Perte rénale de calcium: hypercalciurie rénale</div></td><td class='diff-marker'>+</td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div>** <ins class="diffchange diffchange-inline">&#039;&#039;&#039;</ins>Perte rénale de calcium:<ins class="diffchange diffchange-inline">&#039;&#039;&#039; </ins>hypercalciurie rénale</div></td></tr> <tr><td class='diff-marker'>−</td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;"><div>** Insuffisance en vitamine D: 25-OH vitamine D plasmatique &lt;50 nmol/l</div></td><td class='diff-marker'>+</td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div>** <ins class="diffchange diffchange-inline">&#039;&#039;&#039;</ins>Insuffisance en vitamine D:<ins class="diffchange diffchange-inline">&#039;&#039;&#039; </ins>25-OH vitamine D plasmatique &lt;50 nmol/l</div></td></tr> <tr><td class='diff-marker'> </td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>* &lt;u&gt;Traitement:&lt;/u&gt; &#039;&#039;&#039;calcitriol&#039;&#039;&#039;</div></td><td class='diff-marker'> </td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>* &lt;u&gt;Traitement:&lt;/u&gt; &#039;&#039;&#039;calcitriol&#039;&#039;&#039;</div></td></tr> <tr><td class='diff-marker'> </td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"></td><td class='diff-marker'> </td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"></td></tr> </table>

Julien https://médecine.top/index.php?title=Fonction_parathyro%C3%AFdienne&diff=4939&oldid=prev 2024-01-30T07:45:57Z

<p><span dir="auto"><span class="autocomment">Hyperparathyroïdie secondaire</span></span></p> <table class="diff diff-contentalign-left diff-editfont-monospace" data-mw="interface"> <col class="diff-marker" /> <col class="diff-content" /> <col class="diff-marker" /> <col class="diff-content" /> <tr class="diff-title" lang="fr"> <td colspan="2" style="background-color: #fff; color: #202122; text-align: center;">← Version précédente</td> <td colspan="2" style="background-color: #fff; color: #202122; text-align: center;">Version du 30 janvier 2024 à 07:45</td> </tr><tr><td colspan="2" class="diff-lineno" id="mw-diff-left-l16" >Ligne 16 :</td> <td colspan="2" class="diff-lineno">Ligne 16 :</td></tr> <tr><td class='diff-marker'> </td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"></td><td class='diff-marker'> </td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"></td></tr> <tr><td class='diff-marker'> </td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>=== Hyperparathyroïdie secondaire ===</div></td><td class='diff-marker'> </td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>=== Hyperparathyroïdie secondaire ===</div></td></tr> <tr><td class='diff-marker'>−</td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;"><div>* <del class="diffchange diffchange-inline">Dans le contexte d&#039;une </del>[[insuffisance rénale chronique]]</div></td><td class='diff-marker'>+</td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div>* <ins class="diffchange diffchange-inline">&lt;u&gt;Etiologie:&lt;/u&gt;&lt;ref&gt;https://www.revmed.ch/revue-medicale-suisse/2015/revue-medicale-suisse-456-57/endocrinologie-l-hyperparathyroidie-primaire-asymptomatique-en-2014&lt;/ref&gt;</ins></div></td></tr> <tr><td colspan="2"> </td><td class='diff-marker'>+</td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div><ins class="diffchange diffchange-inline">** </ins>[[insuffisance rénale chronique]] <ins class="diffchange diffchange-inline">(eGFR &lt;60-30 ml/min)</ins></div></td></tr> <tr><td colspan="2"> </td><td class='diff-marker'>+</td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div><ins class="diffchange diffchange-inline">** Médicaments: biphosphonates, anti-épileptiques, furosémide, phosphore</ins></div></td></tr> <tr><td colspan="2"> </td><td class='diff-marker'>+</td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div><ins class="diffchange diffchange-inline">** Malabsorption ou apports calciques diminués: maladie coeliaque, mucoviscidose, maladie de Crohn, status après [[bypass gastrique]]</ins></div></td></tr> <tr><td colspan="2"> </td><td class='diff-marker'>+</td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div><ins class="diffchange diffchange-inline">** Perte rénale de calcium: hypercalciurie rénale</ins></div></td></tr> <tr><td colspan="2"> </td><td class='diff-marker'>+</td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div><ins class="diffchange diffchange-inline">** Insuffisance en vitamine D: 25-OH vitamine D plasmatique &lt;50 nmol/l</ins></div></td></tr> <tr><td class='diff-marker'> </td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>* &lt;u&gt;Traitement:&lt;/u&gt; &#039;&#039;&#039;calcitriol&#039;&#039;&#039;</div></td><td class='diff-marker'> </td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>* &lt;u&gt;Traitement:&lt;/u&gt; &#039;&#039;&#039;calcitriol&#039;&#039;&#039;</div></td></tr> <tr><td class='diff-marker'> </td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"></td><td class='diff-marker'> </td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"></td></tr> </table>

Julien https://médecine.top/index.php?title=Fonction_parathyro%C3%AFdienne&diff=4937&oldid=prev 2024-01-30T06:56:35Z

<p><span dir="auto"><span class="autocomment">Fonction parathyroïdienne</span></span></p> <table class="diff diff-contentalign-left diff-editfont-monospace" data-mw="interface"> <col class="diff-marker" /> <col class="diff-content" /> <col class="diff-marker" /> <col class="diff-content" /> <tr class="diff-title" lang="fr"> <td colspan="2" style="background-color: #fff; color: #202122; text-align: center;">← Version précédente</td> <td colspan="2" style="background-color: #fff; color: #202122; text-align: center;">Version du 30 janvier 2024 à 06:56</td> </tr><tr><td colspan="2" class="diff-lineno" id="mw-diff-left-l1" >Ligne 1 :</td> <td colspan="2" class="diff-lineno">Ligne 1 :</td></tr> <tr><td class='diff-marker'> </td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>== Fonction parathyroïdienne ==</div></td><td class='diff-marker'> </td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>== Fonction parathyroïdienne ==</div></td></tr> <tr><td class='diff-marker'> </td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>[[Fichier:Métabolisme calcium.jpg|500px|vignette|centré|Source: Revue médicale suisse]]</div></td><td class='diff-marker'> </td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>[[Fichier:Métabolisme calcium.jpg|500px|vignette|centré|Source: Revue médicale suisse]]</div></td></tr> <tr><td colspan="2"> </td><td class='diff-marker'>+</td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div><ins style="font-weight: bold; text-decoration: none;"></ins></div></td></tr> <tr><td colspan="2"> </td><td class='diff-marker'>+</td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div><ins style="font-weight: bold; text-decoration: none;">== Investigations ==</ins></div></td></tr> <tr><td colspan="2"> </td><td class='diff-marker'>+</td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div><ins style="font-weight: bold; text-decoration: none;">* PET-choline</ins></div></td></tr> <tr><td colspan="2"> </td><td class='diff-marker'>+</td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div><ins style="font-weight: bold; text-decoration: none;">* Scintigraphie parathyroïdienne</ins></div></td></tr> <tr><td class='diff-marker'> </td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"></td><td class='diff-marker'> </td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"></td></tr> <tr><td class='diff-marker'> </td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>== Hypoparathyroïdie ==</div></td><td class='diff-marker'> </td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>== Hypoparathyroïdie ==</div></td></tr> </table>

Julien https://médecine.top/index.php?title=Fonction_parathyro%C3%AFdienne&diff=4936&oldid=prev 2024-01-30T06:50:12Z

<p><span dir="auto"><span class="autocomment">Hyperparathyroïdie secondaire</span></span></p> <table class="diff diff-contentalign-left diff-editfont-monospace" data-mw="interface"> <col class="diff-marker" /> <col class="diff-content" /> <col class="diff-marker" /> <col class="diff-content" /> <tr class="diff-title" lang="fr"> <td colspan="2" style="background-color: #fff; color: #202122; text-align: center;">← Version précédente</td> <td colspan="2" style="background-color: #fff; color: #202122; text-align: center;">Version du 30 janvier 2024 à 06:50</td> </tr><tr><td colspan="2" class="diff-lineno" id="mw-diff-left-l13" >Ligne 13 :</td> <td colspan="2" class="diff-lineno">Ligne 13 :</td></tr> <tr><td class='diff-marker'> </td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>=== Hyperparathyroïdie secondaire ===</div></td><td class='diff-marker'> </td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>=== Hyperparathyroïdie secondaire ===</div></td></tr> <tr><td class='diff-marker'> </td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>* Dans le contexte d&#039;une [[insuffisance rénale chronique]]</div></td><td class='diff-marker'> </td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>* Dans le contexte d&#039;une [[insuffisance rénale chronique]]</div></td></tr> <tr><td class='diff-marker'>−</td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;"><div>* &lt;u&gt;Traitement :&lt;/u&gt; &#039;&#039;&#039;calcitriol&#039;&#039;&#039;</div></td><td class='diff-marker'>+</td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div>* &lt;u&gt;Traitement:&lt;/u&gt; &#039;&#039;&#039;calcitriol&#039;&#039;&#039;</div></td></tr> <tr><td class='diff-marker'> </td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"></td><td class='diff-marker'> </td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"></td></tr> <tr><td class='diff-marker'> </td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>== Références ==</div></td><td class='diff-marker'> </td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>== Références ==</div></td></tr> </table>

Julien https://médecine.top/index.php?title=Fonction_parathyro%C3%AFdienne&diff=4935&oldid=prev 2024-01-30T06:50:02Z

<p><span dir="auto"><span class="autocomment">Hyperparathyroïdie secondaire</span></span></p> <table class="diff diff-contentalign-left diff-editfont-monospace" data-mw="interface"> <col class="diff-marker" /> <col class="diff-content" /> <col class="diff-marker" /> <col class="diff-content" /> <tr class="diff-title" lang="fr"> <td colspan="2" style="background-color: #fff; color: #202122; text-align: center;">← Version précédente</td> <td colspan="2" style="background-color: #fff; color: #202122; text-align: center;">Version du 30 janvier 2024 à 06:50</td> </tr><tr><td colspan="2" class="diff-lineno" id="mw-diff-left-l13" >Ligne 13 :</td> <td colspan="2" class="diff-lineno">Ligne 13 :</td></tr> <tr><td class='diff-marker'> </td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>=== Hyperparathyroïdie secondaire ===</div></td><td class='diff-marker'> </td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>=== Hyperparathyroïdie secondaire ===</div></td></tr> <tr><td class='diff-marker'> </td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>* Dans le contexte d&#039;une [[insuffisance rénale chronique]]</div></td><td class='diff-marker'> </td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>* Dans le contexte d&#039;une [[insuffisance rénale chronique]]</div></td></tr> <tr><td colspan="2"> </td><td class='diff-marker'>+</td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div><ins style="font-weight: bold; text-decoration: none;">* &lt;u&gt;Traitement :&lt;/u&gt; &#039;&#039;&#039;calcitriol&#039;&#039;&#039;</ins></div></td></tr> <tr><td class='diff-marker'> </td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"></td><td class='diff-marker'> </td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"></td></tr> <tr><td class='diff-marker'> </td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>== Références ==</div></td><td class='diff-marker'> </td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>== Références ==</div></td></tr> </table>

Julien https://médecine.top/index.php?title=Fonction_parathyro%C3%AFdienne&diff=4439&oldid=prev 2021-11-16T05:40:46Z

<p></p> <table class="diff diff-contentalign-left diff-editfont-monospace" data-mw="interface"> <col class="diff-marker" /> <col class="diff-content" /> <col class="diff-marker" /> <col class="diff-content" /> <tr class="diff-title" lang="fr"> <td colspan="2" style="background-color: #fff; color: #202122; text-align: center;">← Version précédente</td> <td colspan="2" style="background-color: #fff; color: #202122; text-align: center;">Version du 16 novembre 2021 à 05:40</td> </tr><tr><td colspan="2" class="diff-lineno" id="mw-diff-left-l1" >Ligne 1 :</td> <td colspan="2" class="diff-lineno">Ligne 1 :</td></tr> <tr><td colspan="2"> </td><td class='diff-marker'>+</td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div><ins style="font-weight: bold; text-decoration: none;">== Fonction parathyroïdienne ==</ins></div></td></tr> <tr><td colspan="2"> </td><td class='diff-marker'>+</td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div><ins style="font-weight: bold; text-decoration: none;">[[Fichier:Métabolisme calcium.jpg|500px|vignette|centré|Source: Revue médicale suisse]]</ins></div></td></tr> <tr><td colspan="2"> </td><td class='diff-marker'>+</td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div><ins style="font-weight: bold; text-decoration: none;"></ins></div></td></tr> <tr><td class='diff-marker'> </td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>== Hypoparathyroïdie ==</div></td><td class='diff-marker'> </td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>== Hypoparathyroïdie ==</div></td></tr> <tr><td class='diff-marker'> </td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div># Exclusion d&#039;une &#039;&#039;&#039;hypomagnésémie&#039;&#039;&#039; pouvant causer une hypoparathyroïdie fonctionnelle</div></td><td class='diff-marker'> </td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div># Exclusion d&#039;une &#039;&#039;&#039;hypomagnésémie&#039;&#039;&#039; pouvant causer une hypoparathyroïdie fonctionnelle</div></td></tr> <tr><td class='diff-marker'> </td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"></td><td class='diff-marker'> </td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"></td></tr> <tr><td class='diff-marker'>−</td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;"><div>== Hyperparathyroïdie primaire ==</div></td><td class='diff-marker'>+</td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div><ins class="diffchange diffchange-inline">== Hyperparathyroïdie ==</ins></div></td></tr> <tr><td colspan="2"> </td><td class='diff-marker'>+</td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div><ins class="diffchange diffchange-inline">=</ins>== Hyperparathyroïdie primaire <ins class="diffchange diffchange-inline">=</ins>==</div></td></tr> <tr><td class='diff-marker'> </td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>* &lt;u&gt;Asymptomatique:&lt;/u&gt; suivi à 6−12 mois</div></td><td class='diff-marker'> </td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>* &lt;u&gt;Asymptomatique:&lt;/u&gt; suivi à 6−12 mois</div></td></tr> <tr><td class='diff-marker'> </td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>* &lt;u&gt;Symptomatique:&lt;/u&gt; Guideline-recommended indications for parathyroidectomy include increase in serum calcium level ≥1 mg/dL (0.25 mmol/L) above upper limit of normal; creatinine clearance &lt;60 mL/min, 24-hour urine calcium &gt;400 mg/day (&gt;10 mmol/day), or increased stone risk by biochemical stone risk analysis; presence of nephrolithiasis or nephrocalcinosis by radiograph, ultrasound, or CT; T-score (on DEXA scan) of less than or equal to −2.5 at any site or evidence of vertebral fracture; and age younger than 50 years. Parathyroidectomy is also indicated in patients in whom medical surveillance is neither desired nor possible, and those with complications of hyperparathyroidism including significant bone, kidney, gastrointestinal, or neuromuscular symptoms.</div></td><td class='diff-marker'> </td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>* &lt;u&gt;Symptomatique:&lt;/u&gt; Guideline-recommended indications for parathyroidectomy include increase in serum calcium level ≥1 mg/dL (0.25 mmol/L) above upper limit of normal; creatinine clearance &lt;60 mL/min, 24-hour urine calcium &gt;400 mg/day (&gt;10 mmol/day), or increased stone risk by biochemical stone risk analysis; presence of nephrolithiasis or nephrocalcinosis by radiograph, ultrasound, or CT; T-score (on DEXA scan) of less than or equal to −2.5 at any site or evidence of vertebral fracture; and age younger than 50 years. Parathyroidectomy is also indicated in patients in whom medical surveillance is neither desired nor possible, and those with complications of hyperparathyroidism including significant bone, kidney, gastrointestinal, or neuromuscular symptoms.</div></td></tr> <tr><td class='diff-marker'> </td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>* Vitamin D deficiency is common in patients with primary hyperparathyroidism (HPT) due to increased conversion of 25-hydroxyvitamin D to 1,25-dihydroxyvitamin D. &#039;&#039;&#039;Supplementation of vitamin D&#039;&#039;&#039; in patients with HPT has been shown to reduce parathyroid hormone levels, decrease bone turnover, and improve bone mineral density.</div></td><td class='diff-marker'> </td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>* Vitamin D deficiency is common in patients with primary hyperparathyroidism (HPT) due to increased conversion of 25-hydroxyvitamin D to 1,25-dihydroxyvitamin D. &#039;&#039;&#039;Supplementation of vitamin D&#039;&#039;&#039; in patients with HPT has been shown to reduce parathyroid hormone levels, decrease bone turnover, and improve bone mineral density.</div></td></tr> <tr><td class='diff-marker'> </td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"></td><td class='diff-marker'> </td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"></td></tr> <tr><td class='diff-marker'>−</td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;"><div>== Hyperparathyroïdie secondaire ==</div></td><td class='diff-marker'>+</td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div><ins class="diffchange diffchange-inline">=</ins>== Hyperparathyroïdie secondaire <ins class="diffchange diffchange-inline">=</ins>==</div></td></tr> <tr><td class='diff-marker'> </td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>* Dans le contexte d&#039;une [[insuffisance rénale chronique]]</div></td><td class='diff-marker'> </td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>* Dans le contexte d&#039;une [[insuffisance rénale chronique]]</div></td></tr> <tr><td class='diff-marker'> </td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"></td><td class='diff-marker'> </td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"></td></tr> </table>

Julien https://médecine.top/index.php?title=Fonction_parathyro%C3%AFdienne&diff=3671&oldid=prev 2021-06-02T04:46:54Z

<p></p> <table class="diff diff-contentalign-left diff-editfont-monospace" data-mw="interface"> <col class="diff-marker" /> <col class="diff-content" /> <col class="diff-marker" /> <col class="diff-content" /> <tr class="diff-title" lang="fr"> <td colspan="2" style="background-color: #fff; color: #202122; text-align: center;">← Version précédente</td> <td colspan="2" style="background-color: #fff; color: #202122; text-align: center;">Version du 2 juin 2021 à 04:46</td> </tr><tr><td colspan="2" class="diff-lineno" id="mw-diff-left-l6" >Ligne 6 :</td> <td colspan="2" class="diff-lineno">Ligne 6 :</td></tr> <tr><td class='diff-marker'> </td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>* &lt;u&gt;Symptomatique:&lt;/u&gt; Guideline-recommended indications for parathyroidectomy include increase in serum calcium level ≥1 mg/dL (0.25 mmol/L) above upper limit of normal; creatinine clearance &lt;60 mL/min, 24-hour urine calcium &gt;400 mg/day (&gt;10 mmol/day), or increased stone risk by biochemical stone risk analysis; presence of nephrolithiasis or nephrocalcinosis by radiograph, ultrasound, or CT; T-score (on DEXA scan) of less than or equal to −2.5 at any site or evidence of vertebral fracture; and age younger than 50 years. Parathyroidectomy is also indicated in patients in whom medical surveillance is neither desired nor possible, and those with complications of hyperparathyroidism including significant bone, kidney, gastrointestinal, or neuromuscular symptoms.</div></td><td class='diff-marker'> </td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>* &lt;u&gt;Symptomatique:&lt;/u&gt; Guideline-recommended indications for parathyroidectomy include increase in serum calcium level ≥1 mg/dL (0.25 mmol/L) above upper limit of normal; creatinine clearance &lt;60 mL/min, 24-hour urine calcium &gt;400 mg/day (&gt;10 mmol/day), or increased stone risk by biochemical stone risk analysis; presence of nephrolithiasis or nephrocalcinosis by radiograph, ultrasound, or CT; T-score (on DEXA scan) of less than or equal to −2.5 at any site or evidence of vertebral fracture; and age younger than 50 years. Parathyroidectomy is also indicated in patients in whom medical surveillance is neither desired nor possible, and those with complications of hyperparathyroidism including significant bone, kidney, gastrointestinal, or neuromuscular symptoms.</div></td></tr> <tr><td class='diff-marker'> </td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>* Vitamin D deficiency is common in patients with primary hyperparathyroidism (HPT) due to increased conversion of 25-hydroxyvitamin D to 1,25-dihydroxyvitamin D. &#039;&#039;&#039;Supplementation of vitamin D&#039;&#039;&#039; in patients with HPT has been shown to reduce parathyroid hormone levels, decrease bone turnover, and improve bone mineral density.</div></td><td class='diff-marker'> </td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>* Vitamin D deficiency is common in patients with primary hyperparathyroidism (HPT) due to increased conversion of 25-hydroxyvitamin D to 1,25-dihydroxyvitamin D. &#039;&#039;&#039;Supplementation of vitamin D&#039;&#039;&#039; in patients with HPT has been shown to reduce parathyroid hormone levels, decrease bone turnover, and improve bone mineral density.</div></td></tr> <tr><td colspan="2"> </td><td class='diff-marker'>+</td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div><ins style="font-weight: bold; text-decoration: none;"></ins></div></td></tr> <tr><td colspan="2"> </td><td class='diff-marker'>+</td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div><ins style="font-weight: bold; text-decoration: none;">== Hyperparathyroïdie secondaire ==</ins></div></td></tr> <tr><td colspan="2"> </td><td class='diff-marker'>+</td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div><ins style="font-weight: bold; text-decoration: none;">* Dans le contexte d&#039;une [[insuffisance rénale chronique]]</ins></div></td></tr> <tr><td class='diff-marker'> </td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"></td><td class='diff-marker'> </td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"></td></tr> <tr><td class='diff-marker'> </td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>== Références ==</div></td><td class='diff-marker'> </td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>== Références ==</div></td></tr> </table>

Julien https://médecine.top/index.php?title=Fonction_parathyro%C3%AFdienne&diff=2852&oldid=prev 2020-06-22T12:46:14Z

<p><span dir="auto"><span class="autocomment">Hyperparathyroïdie primaire</span></span></p> <table class="diff diff-contentalign-left diff-editfont-monospace" data-mw="interface"> <col class="diff-marker" /> <col class="diff-content" /> <col class="diff-marker" /> <col class="diff-content" /> <tr class="diff-title" lang="fr"> <td colspan="2" style="background-color: #fff; color: #202122; text-align: center;">← Version précédente</td> <td colspan="2" style="background-color: #fff; color: #202122; text-align: center;">Version du 22 juin 2020 à 12:46</td> </tr><tr><td colspan="2" class="diff-lineno" id="mw-diff-left-l5" >Ligne 5 :</td> <td colspan="2" class="diff-lineno">Ligne 5 :</td></tr> <tr><td class='diff-marker'> </td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>* &lt;u&gt;Asymptomatique:&lt;/u&gt; suivi à 6−12 mois</div></td><td class='diff-marker'> </td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>* &lt;u&gt;Asymptomatique:&lt;/u&gt; suivi à 6−12 mois</div></td></tr> <tr><td class='diff-marker'> </td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>* &lt;u&gt;Symptomatique:&lt;/u&gt; Guideline-recommended indications for parathyroidectomy include increase in serum calcium level ≥1 mg/dL (0.25 mmol/L) above upper limit of normal; creatinine clearance &lt;60 mL/min, 24-hour urine calcium &gt;400 mg/day (&gt;10 mmol/day), or increased stone risk by biochemical stone risk analysis; presence of nephrolithiasis or nephrocalcinosis by radiograph, ultrasound, or CT; T-score (on DEXA scan) of less than or equal to −2.5 at any site or evidence of vertebral fracture; and age younger than 50 years. Parathyroidectomy is also indicated in patients in whom medical surveillance is neither desired nor possible, and those with complications of hyperparathyroidism including significant bone, kidney, gastrointestinal, or neuromuscular symptoms.</div></td><td class='diff-marker'> </td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>* &lt;u&gt;Symptomatique:&lt;/u&gt; Guideline-recommended indications for parathyroidectomy include increase in serum calcium level ≥1 mg/dL (0.25 mmol/L) above upper limit of normal; creatinine clearance &lt;60 mL/min, 24-hour urine calcium &gt;400 mg/day (&gt;10 mmol/day), or increased stone risk by biochemical stone risk analysis; presence of nephrolithiasis or nephrocalcinosis by radiograph, ultrasound, or CT; T-score (on DEXA scan) of less than or equal to −2.5 at any site or evidence of vertebral fracture; and age younger than 50 years. Parathyroidectomy is also indicated in patients in whom medical surveillance is neither desired nor possible, and those with complications of hyperparathyroidism including significant bone, kidney, gastrointestinal, or neuromuscular symptoms.</div></td></tr> <tr><td colspan="2"> </td><td class='diff-marker'>+</td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div><ins style="font-weight: bold; text-decoration: none;">* Vitamin D deficiency is common in patients with primary hyperparathyroidism (HPT) due to increased conversion of 25-hydroxyvitamin D to 1,25-dihydroxyvitamin D. &#039;&#039;&#039;Supplementation of vitamin D&#039;&#039;&#039; in patients with HPT has been shown to reduce parathyroid hormone levels, decrease bone turnover, and improve bone mineral density.</ins></div></td></tr> <tr><td class='diff-marker'> </td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"></td><td class='diff-marker'> </td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"></td></tr> <tr><td class='diff-marker'> </td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>== Références ==</div></td><td class='diff-marker'> </td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>== Références ==</div></td></tr> </table>

Julien https://médecine.top/index.php?title=Fonction_parathyro%C3%AFdienne&diff=2847&oldid=prev 2020-06-22T10:56:04Z

<p></p> <table class="diff diff-contentalign-left diff-editfont-monospace" data-mw="interface"> <col class="diff-marker" /> <col class="diff-content" /> <col class="diff-marker" /> <col class="diff-content" /> <tr class="diff-title" lang="fr"> <td colspan="2" style="background-color: #fff; color: #202122; text-align: center;">← Version précédente</td> <td colspan="2" style="background-color: #fff; color: #202122; text-align: center;">Version du 22 juin 2020 à 10:56</td> </tr><tr><td colspan="2" class="diff-lineno" id="mw-diff-left-l1" >Ligne 1 :</td> <td colspan="2" class="diff-lineno">Ligne 1 :</td></tr> <tr><td colspan="2"> </td><td class='diff-marker'>+</td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div><ins style="font-weight: bold; text-decoration: none;">== Hypoparathyroïdie ==</ins></div></td></tr> <tr><td colspan="2"> </td><td class='diff-marker'>+</td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div><ins style="font-weight: bold; text-decoration: none;"># Exclusion d&#039;une &#039;&#039;&#039;hypomagnésémie&#039;&#039;&#039; pouvant causer une hypoparathyroïdie fonctionnelle</ins></div></td></tr> <tr><td colspan="2"> </td><td class='diff-marker'>+</td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div><ins style="font-weight: bold; text-decoration: none;"></ins></div></td></tr> <tr><td class='diff-marker'> </td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>== Hyperparathyroïdie primaire ==</div></td><td class='diff-marker'> </td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>== Hyperparathyroïdie primaire ==</div></td></tr> <tr><td class='diff-marker'> </td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>* &lt;u&gt;Asymptomatique:&lt;/u&gt; suivi à 6−12 mois</div></td><td class='diff-marker'> </td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>* &lt;u&gt;Asymptomatique:&lt;/u&gt; suivi à 6−12 mois</div></td></tr> </table>

Julien https://médecine.top/index.php?title=Fonction_parathyro%C3%AFdienne&diff=2846&oldid=prev 2020-06-22T10:45:00Z

<p></p> <table class="diff diff-contentalign-left diff-editfont-monospace" data-mw="interface"> <col class="diff-marker" /> <col class="diff-content" /> <col class="diff-marker" /> <col class="diff-content" /> <tr class="diff-title" lang="fr"> <td colspan="2" style="background-color: #fff; color: #202122; text-align: center;">← Version précédente</td> <td colspan="2" style="background-color: #fff; color: #202122; text-align: center;">Version du 22 juin 2020 à 10:45</td> </tr><tr><td colspan="2" class="diff-lineno" id="mw-diff-left-l2" >Ligne 2 :</td> <td colspan="2" class="diff-lineno">Ligne 2 :</td></tr> <tr><td class='diff-marker'> </td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>* &lt;u&gt;Asymptomatique:&lt;/u&gt; suivi à 6−12 mois</div></td><td class='diff-marker'> </td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>* &lt;u&gt;Asymptomatique:&lt;/u&gt; suivi à 6−12 mois</div></td></tr> <tr><td class='diff-marker'> </td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>* &lt;u&gt;Symptomatique:&lt;/u&gt; Guideline-recommended indications for parathyroidectomy include increase in serum calcium level ≥1 mg/dL (0.25 mmol/L) above upper limit of normal; creatinine clearance &lt;60 mL/min, 24-hour urine calcium &gt;400 mg/day (&gt;10 mmol/day), or increased stone risk by biochemical stone risk analysis; presence of nephrolithiasis or nephrocalcinosis by radiograph, ultrasound, or CT; T-score (on DEXA scan) of less than or equal to −2.5 at any site or evidence of vertebral fracture; and age younger than 50 years. Parathyroidectomy is also indicated in patients in whom medical surveillance is neither desired nor possible, and those with complications of hyperparathyroidism including significant bone, kidney, gastrointestinal, or neuromuscular symptoms.</div></td><td class='diff-marker'> </td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>* &lt;u&gt;Symptomatique:&lt;/u&gt; Guideline-recommended indications for parathyroidectomy include increase in serum calcium level ≥1 mg/dL (0.25 mmol/L) above upper limit of normal; creatinine clearance &lt;60 mL/min, 24-hour urine calcium &gt;400 mg/day (&gt;10 mmol/day), or increased stone risk by biochemical stone risk analysis; presence of nephrolithiasis or nephrocalcinosis by radiograph, ultrasound, or CT; T-score (on DEXA scan) of less than or equal to −2.5 at any site or evidence of vertebral fracture; and age younger than 50 years. Parathyroidectomy is also indicated in patients in whom medical surveillance is neither desired nor possible, and those with complications of hyperparathyroidism including significant bone, kidney, gastrointestinal, or neuromuscular symptoms.</div></td></tr> <tr><td colspan="2"> </td><td class='diff-marker'>+</td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div><ins style="font-weight: bold; text-decoration: none;"></ins></div></td></tr> <tr><td colspan="2"> </td><td class='diff-marker'>+</td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div><ins style="font-weight: bold; text-decoration: none;">== Références ==</ins></div></td></tr> <tr><td colspan="2"> </td><td class='diff-marker'>+</td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div><ins style="font-weight: bold; text-decoration: none;">MKSAP 18</ins></div></td></tr> <tr><td colspan="2"> </td><td class='diff-marker'>+</td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div><ins style="font-weight: bold; text-decoration: none;"></ins></div></td></tr> <tr><td colspan="2"> </td><td class='diff-marker'>+</td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div><ins style="font-weight: bold; text-decoration: none;">[[Category:Endocrinologie]]</ins></div></td></tr> </table>

Julien